Read open access via bit.ly/4eiZRnl "Development of a Clinical and Biomarker-Based Score to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea"
#GItwitter #colitis #diarrhoea
0
2
1
237
Available to read 'open access' via bit.ly/4igTljq "Clinical Trial: Capsule Sponge as a Non-Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study"
#GItwitter #EoE
0
7
6
887
"Management and Outcomes of Bleeding Ectopic Varices in Patients With Liver Cirrhosis: A Systematic Review and Pooled Analysis" published at bit.ly/3UVbURd
#livertwitter #varices #cirrhosis
0
2
2
311
Read open access via bit.ly/4kjDm5o "Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients"
#GItwitter #diarrhoea #colon
0
3
1
309
"Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease" avaible to read via bit.ly/4A1s0I7
#GItwitter #IBD #infliximab
0
1
0
180
Read open access via bit.ly/3UinXro "Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non-Anticoagulated Patients".
#GItwitter #GIbleeding
0
3
2
281
"Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic Therapy" by Kelly CR et al is available to read at bit.ly/4i0QDhY
#GItwitter #microbiota #CDI #FMT
0
3
3
321
Read open access via bit.ly/4izC5WE "Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study"
#GItwitter #oesophagus #GIcancer
0
4
2
363
Read open access via bit.ly/4jNVap6 "Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease"
#GItwitter #IBD #surgery
0
6
7
1,482
"Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial" is available to read open access via bit.ly/4hMiVeJ
#EoE #GItwitter
0
4
3
517
Read via bit.ly/4dAYKiH "Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies"
#GItwitter #IBD
0
3
6
677
Read via bit.ly/4hwAKOB "Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity"
#livertwitter #PSC #PBC
0
4
7
488
"Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection" - read via bit.ly/4hUyvWK
#HBV #livertwitter #HCC
1
2
1
292
"Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis" is available to read open access via bit.ly/3Vi8KXH
#livertwitter #AIH
0
6
6
551
Read via bit.ly/4hmFDLv "Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study"
#GItwitter #IBD #vedolizumab
0
2
3
370
"Meta-Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" - read via bit.ly/4yePOaH
#livertwitter #metanalysis #pruritus
0
4
7
531
Read open access via bit.ly/4yXyrLM "Pathogen-Specific Bloodstream Infections Associated With Tumour Necrosis Factor-α Inhibitors, Vedolizumab and Ustekinumab in Inflammatory Bowel Disease: A Danish Nationwide Case-Control Study 2010–2024"
#IBD #GItwitter #TNF
0
3
6
365
"Development and Prospective Validation of a Machine Learning-Based Mobile Application (CROHN'S AID) for Differentiating Crohn's Disease From Intestinal Tuberculosis in Tuberculosis-Endemic Regions" is now published at bit.ly/3SZIFvT
#GItwitter #Crohns #IBD
0
1
4
323
Available to read 'open access' via bit.ly/3Vah2Ri "Medication Use and Risk of Microscopic Colitis: A Propensity-Matched Analysis of US Adults ≥ 50 Years (2014–2024)"
#GItwitter #microscopiccolitis #NSAIDs #PPIs #SSRIs
0
13
17
1,358
Read open access via bit.ly/4jaWz8T "Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta"
#livertwitter #HDV #HBV #HCC
0
3
1
310